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The Dementias Platform UK (DPUK) Data Portal is a data repository facilitating access to data for 3 370 929 
individuals in 42 cohorts. The Data Portal is an end-to-end data management solution providing a secure, fully 
auditable, remote access environment for the analysis of cohort data. All projects utilising the data are by default 
collaborations with the cohort research teams generating the data.  
The Data Portal uses UK Secure eResearch Platform (UKSeRP) infrastructure to provide three core utilities: 
data discovery, access, and analysis. These are delivered using a 7 layered architecture comprising: data 
ingestion, data curation, platform interoperability, data discovery, access brokerage, data analysis and 
knowledge preservation. Automated, streamlined, and standardised procedures reduce the administrative burden 
for all stakeholders, particularly for requests involving multiple independent datasets, where a single request 
may be forwarded to multiple data controllers. Researchers are provided with their own secure ‘lab’ using 
VMware which is accessed using two factor authentication.   
Over the last 2 years, 160 project proposals involving 579 individual cohort data access requests were received. 
These were received from 268 applicants spanning 72 institutions (56 academic, 13 commercial, 3 government) 
in 16 countries with 84 requests involving multiple cohorts. Project are varied including multi-modal, machine 
learning, and Mendelian randomisation analyses. Data access is usually free at point of use although a small 
number of cohorts require a data access fee. 
 
  




Here we describe the Dementias Platform UK (DPUK) Data Portal (https://portal.dementiasplatform.uk/) (1). The 
Data Portal is a collaboration between DPUK and a growing number of cohort research teams who wish to make 
their data globally accessible. DPUK was established by the Medical Research Council (MRC) to accelerate the 
development of new treatments for dementia. The Data Portal is a component infrastructure of DPUK, designed 
to exploit the opportunities provided by cohort data to inform experimental medicine and to improve access to 
cohort data more widely. It is a data repository facilitating access to data for 3 370 929 individuals in 42 cohorts. 
The Data Portal provides a secure, fully auditable, remote access environment for the analysis of cohort data. The 
Data Portal supports the FAIR principles (Findability, Accessibility, Interoperability and Reusability) to improve 
the infrastructure supporting the re-use of data (2) 
Arguments for multi-cohort-focused data repositories include: 1) as research questions focus on smaller effect 
sizes, access is required to data at-scale to achieve statistical purchase, 2) as emerging research questions become 
more complex, access to diverse multi-modal data is needed for rigorous hypothesis testing, 3) as scientific rigour 
increases there is growing recognition of the value of triangulation and replication using independent datasets, 4) 
as cohort datasets increase in size the  transfer of large datasets is decreasingly feasible, 5) as cohort datasets 
become more complex the mastering of bespoke data models for survey, omics (genomics, proteomics and 
metabolomics), imaging and device data becomes burdensome, 6) as cohort datasets become more sensitive the 
non-auditable use of data is decreasingly acceptable. Whilst these issues can be addressed individually, the Data 
Portal provides an integrated solution. 
The Data Portal is an end-to-end data management solution designed to support cohort data sharing. All projects 
utilising the data are by default collaborations with the cohort research teams generating the data. Although it 
has the three core utilities of data discovery, access, and analysis, to achieve these it operates across seven layers 
(Figure).  
Layer 1- Data Ingestion: The data journey begins with upload to the Data Portal. Datasets and data dictionaries 
are received from cohorts on an ‘as-is’ basis along with other supporting documentation. The Data Portal operates 
within the UK Secure eResearch Platform (UKSeRP) environment according to ISO 27001 (3) and operates 
exclusively as a data processor according to the UK Data Protection Act 2018 (4) and EU General Data Protection 
Regulation 2016 (5). DPUK facilitates the legal engagements necessary for data transfer into the Data Portal on 
behalf of data controllers, by ensuring robust contractual arrangements are in place as an overarching mechanism 
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for data governance and use (6). In practice the data controller is considered to be the principal investigator for 
the dataset. A dataset is removed from the Data Portal upon receipt of a wet-ink signature request from the data 
controller. 
Layer 2- Data curation: Upon receipt, ‘native’ data are curated to a common data model (C-Surv). The C-Surv 
ontology is designed to simplify the analytic challenge of working across multiple datasets and multiple modalities 
by providing standard structure, variable naming and value labelling conventions. Other data models, CDISC (7), 
OMOP (8), or HPO (9) involve structural complexity that is rarely relevant to cohort-based analyses. An example 
variable name using the C-Surv model is given below: 
GEN05_PAINCHESTEVR_0_1 
The cohort is identified using a three digit alphabetic character (GEN for Generation Scotland), and category-
level data by a two digit numeric character (05 for physical health status). The measure is described by an 
alphanumeric acronym (PAINCHESTEVR for: Do you ever get pain or discomfort in your chest?). This is 
followed by an integer giving the number of repeat measurements within a study wave (_0 indicates there were 
no repeat measurements). Finally, an integer suffix indicates study wave (_1 for recruitment, _2 for the first 
follow-up, etc.). This data model is a contribution to a wider debate on how global access to cohort data can be 
achieved.   
C-Surv is optimised for the analysis of ‘flat-file’ data. Higher order data must be pre-processed prior to curation. 
The XNAT (10) imaging platform is used to receive and process DICOM and NIfTI files. For genetics, variant 
call format and allele frequency data may be uploaded. C-Surv is also designed to improve the efficiency of data 
selection and management from the applicants and administrators’ perspectives. There are 22 categories and 132 
sub-categories, which may be used for data selection as an alternative to individual variable selection. The 
ontology is machine-readable for mapping to other ontologies. Researchers may request access to either native or 
curated data. Standardisation does not imply harmonisation i.e. comparability (equivalence) of values and/or 
distributions across variables.  Data harmonisation is implicitly purpose specific. DPUK undertakes a very limited 
harmonisation programme solely to support data discovery (see Layer 4). Data curation is resource intensive and 
is ongoing. To accelerate the process we are developing machine-learning approaches, which currently achieve 
an 80% accuracy. 
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Layer 3- Interoperability: We anticipate a global mixed-model data access environment that respects sovereign 
boundaries and requires the highest levels of security. In practice, this involves the integration of individual 
participant data across datasets (‘pooled’ analyses) and the integration of summary data across datasets 
(‘federated’ analyses). Both models require interoperability between data platforms across national boundaries. 
DPUK supports the development of interoperability in several ways. In partnership with UKSeRP, we provide 
access to our software solutions to other data platforms to facilitate architectural compatibility. We also engage 
with other data platforms to develop interoperability across architectures. In collaboration with Gates Ventures 
and other data platforms, we are working to develop a high-level data-gateway for cross-platform data access. 
Layer 4- Data discovery: A tiered data discovery pathway begins with the Cohort Matrix (11) which provides a 
high-level comparison of data availability for each cohort.  The Cohort Directory (12) enables detailed exploration 
across cohorts using a range of metadata categories. The Cohort Explorer (13) provides access to a set of 30 
variables harmonised across cohorts to enable feasibility analysis. Adding cohorts to the Cohort Explorer is 
ongoing. As the Cohort Explorer provides access to harmonised data, login to the Data Portal is required. Data 
discovery is a dynamic area and the development of increasingly ergonomic and intuitive tools is anticipated.  
This is likely to include the identification of high priority variable sets and variable selection algorithms through 
the analysis of user-activity and the development of application programming interfaces (APIs) to rapidly 
reproduce data selection (see Layer 7). DPUK welcomes user feedback and collaboration to inform an ongoing 
programme of discovery tool development. 
Layer 5- Data Access brokerage: Automated third-party brokerage, allowing submission of a single data access 
request to multiple data controllers, reduces the researcher administrative burden. Standard cross-cohort access 
agreements and streamlined decision-making procedures simplifies the application and approvals process for all 
stakeholders.  Access requests can be specified at the level of detail required by the data controller and if approval 
is granted, a standard access agreement must be completed by both parties prior to access being granted. The 
application form is a synthesis of key issues that are addressed by most, if not all, the individual cohort access 
management procedures, fail-fast criteria have been developed to facilitate rapid and transparent decision-making 
by data controllers. These comprise the proposal not being in the public interest, potential identifiability of 
participants, no clear scientific rationale, no appropriate analysis plan, or a conflict of scientific interest. Upon 
access approval by a cohort data access committee (DAC), completion by the applicant of a data access agreement 
is required prior to access being granted.  Upon receipt of a completed data access agreement, data access is 
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granted within several days for any one cohort (14).  Data access is normally free at the point of use with a small 
number of cohorts levying a data access fee (Table). 
Layer 6- Data analysis:  The analysis environment is VMware based with each researcher allocated their own 
private personal ‘lab’ (desktop) into which approved data are moved, and from which they can access a range of 
pre-loaded generic and specialist software packages. Bespoke software may also be uploaded upon approval. 
VMware clients are available for a range of operating system including Windows, Linux, IOS, Mac, and Android. 
A standard desktop is provided for researchers seeking to access standard phenotypic data on the Portal. The 
standard desktop has the following specification: Windows 7/10, 8GB RAM, and 4 CPUs. It is pre-loaded with 
R, RStudio, SPSS, SAS, Stata, Python, Eclipse, MATLAB, SQL Server Management Studio, Microsoft Office. 
Statistical software, such as R and Python, can connect to its official library/package/index directory to enable 
configuration of software on a per-user basis. Larger desktops are available on request (32GB RAM with 8 CPUs, 
128GB RAM and 16CPUs) which are more suitable for large-scale multi-modal analyses such as omics and 
imaging analyses, and for machine learning.  
Storage is scalable according to the study requirements, with basic access to data stored on our systems free to all 
users. Studies needing unusually large amounts of storage to ingress their own at-scale data will be subject to 
potential charges which will be discussed with researchers as part of the desktop set-up. High Performance 
Computing and non-Windows operating systems are available upon request. The Data Portal also offers consortia-
based workspace; providing an independent and transparent storage, access and analysis solution for use by 
multiple institutions.    
Two-factor authentication is required to access approved datasets. This involves the provision of a username with 
password creation, and an authentication code generated by an app on a mobile device of the applicant’s choosing. 
Data may not be removed from the Portal. However, tables, graphs and scripts for export are submitted to the data 
export panel for approval. Manuscripts may be prepared in the Data Portal so that collaborators who are registered 
users may contribute without the need for manuscript download. A facility for import is also available, enabling 
researchers to upload scripts and additional datasets from outside the Data Portal to reside within their approved 
DPUK datasets.  
Layer 7- Knowledge environment: Cohort data grow in quantity and can be complex, but ultimately there is the 
need for the transition from data to knowledge and insight. In response to this challenge, the Data Portal is 
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developing a Knowledge Hub to organise and make information readily accessible on the key activities of the 
Data Portal. The immediate purpose of the knowledge Hub is to enable collaborative knowledge building; 
enabling researchers to understand what is available, what is known, and where there are knowledge gaps. It also 
serves as a knowledge preservation repository enabling the storage of linked datasets and analysis code with 
persistent identifiers for rapid access and replication. DPUK welcomes collaboration in the development of this 
hub. 
Application for access can be made through the Data Portal https://portal.dementiasplatform.uk/ (15) 
Results 
Data resources: DPUK collaborates with 42 clinical and population cohorts (Table). Of these, 24 (n=1 410 302) 
have either completed or are in the process of uploading full or partial datasets and 18 (n=1 960, 627) upload data 
on a per-project basis. The data are diverse. Clinical cohort studies include familial disease cohorts (16, 17), 
disease focused patient cohorts (18, 19), ageing focused population cohorts (20-23), re-purposed cardiovascular 
cohorts (24, 25), birth cohorts (26, 27), repurposed cancer cohorts (28, 29), and disease agnostic cohorts (30-32). 
In terms of real world evidence, the Data Portal provides access to an e-cohort (SAIL-DeC) covering health 
records for 1.2m individuals including 130k dementia cases (33).  Data availability varies according to cohort but 
includes epidemiologic survey, imaging, genetics, and linked administrative data. The Data Portal provides a link 
to the UK-CRIS Network for natural language processing of 2.5m UK mental health records (34). Overall, these 
cohorts and the data modalities represented, provide an unusually rich and complex data environment.  
Data resource use: From launch in November 2017 to end of January 2019, 160 project proposals involving 579 
individual cohort data access requests were received. These were received from 268 applicants spanning 72 
institutions (56 academic, 13 commercial, 3 government) in 16 countries with 84 requests involving multiple 
cohorts.  
Of the 160 project proposals, 40 failed triage due to under-specification and were not forwarded to cohort DACs. 
The 120 projects that were forwarded to DACs involved 396 individual cohort access requests, 19 of which were 
withdrawn by the applicant pre-approval. Of the 377 access requests considered 171 (45%) were approved, 80 
(21%) were declined, 78 (21%) were closed following non-response after 200 days from either the applicant or 
the cohort, 19 (5%) ceased after approval and 29 (8%) are in process. Of the 80 declined requests, 49 (61%) were 
due to the data requested either not existing or not being relevant for the analysis.  
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The data requests were diverse. Projects include Mendelian randomisation, imaging, psychometric, and machine 
learning studies, alongside risk stratification studies and dementia prediction and diagnosis modelling. Other 
studies are less dementia specific including trajectories of longitudinal assessment of comorbidities between 
mental health, hormonal indicators and cognitive change; the impact of child adversity on adult outcomes; the 
longitudinal tracking and determinants of well-being and cognitive performance; and successful cognitive ageing 
in 90+ year olds.  
To facilitate innovative and exploratory analyses, the Data Portal can be configured as a ‘sandbox’ environment, 
without compromising data security or cohort governance principles. An example of this was the hosting of a 
three-day multidisciplinary workshop (datathon) for 40 data scientists at the Alan Turing Institute utilising the 
Deep and Frequent Phenotyping pilot study data (35). These multi-modal data include Magneto-encephalography 
(MEG), Positron Emission Tomography (PET), structural and functional MRI, ophthalmology, gait, and serial 
cognitive and clinical assessment. The Data Portal was used to host 25 data scientists in a datathon at the 
University of Exeter and Swansea University, during which traditional regression and machine learning 
procedures were used to interrogate the data within the virtual desktop interface. A datathon at the University of 
East Anglia hosted 60 attendees, mostly early career researchers, using data from the Deep and Frequent 
Phenotyping Study (35), the English Longitudinal study of Ageing (20), and the Caerphilly Prospective Study 
(36). The datathon programme is ongoing with a further 6 planned for 2019. The sandbox environment is also 
suitable for teaching and training purposes as it enables access to standardised datasets by multiple users within a 
secure environment. 
Portal performance: Data Portal utility varies according to the extent that standardised procedures are used.   
Currently, 38 cohorts (90%) accept our standard legal agreements, 28 cohorts (67%) accept our streamlined data 
access process, with a further 13 accepting a DPUK application as an initial enquiry. For variable selection, 22 
(52%) cohorts accept the use of our variable selection tools with the remainder requiring the use of cohort-specific 
variable selection tools (Table). 
Triage is rapid, usually upon receipt. Cohort DAC decision times vary according to the complexity of the project, 
clarity of the proposal, and the DAC meeting frequency. DPUK policy is to consider a project closed (in effect 
expired) if there has been no response from the cohort DAC within 200 days. Our target DAC response time is 28 
days. Current performance has a median value of 28 days (mean=40). Time from approval to data access is 
dependent on the completion of the data access agreement by the applicant. Where data are already uploaded to 
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the Data Portal access is typically given with 24 hours of receiving the completed Data Access Agreement. Where 
data are uploaded on a per-project basis, access is dependent on the cohort data management process. Typically, 
upload of native data (not curated by DPUK) occurs within 2 weeks and can be made accessible to the researcher 
immediately.  
Discussion 
Rapid data access continues to be a challenge for researchers, funders, and governments. The DPUK Data Portal 
is one of several initiatives to address this issue. In the dementia space, other data platforms are available. The 
JPND Global Cohort Directory (37) provides contact details for 175 cohorts (n=3 586 109) whilst the IALSA 
Network (38) provides details for 110 cohorts (n=1 485 410). More sophisticated and convenient data discovery 
tools are provided by GAAIN (39) with 47 cohorts (n=480 020). GAAIN also offers centralised processing for 
selected datasets. EMIF-AD (38) offers a comprehensive data harmonisation programme for a selection of their 
60 catalogued cohorts (n=135 959) and 18 electronic health records datasets (n=65M). For selected datasets EMIF-
AD provides centralised cohort data processing facilities through the TranSMART platform (40). 
Data Portal Benefits: However, in providing independent trusted third-party data management, the data 
repository approach has several benefits. Although the Data Portal is optimised for dementia, its remote access 
model provides a generic solution that can be adapted to any outcome for which relevant data are available.  
Specifically, by automating, streamlining and standardising procedures, decision-making can be more precise, 
quicker, and more transparent, and the practice of repeated data transfers avoided. 
For cohort research teams a repository substantially reduces the administrative burden of routine data management 
tasks, particularly avoiding repeated data transfers. This assists cohorts in meeting their data sharing obligations, 
and releases cohort-based data scientists to focus on increasing the scientific value of their data.  
For researchers a repository provides a single point of contact and a single standard procedure for accessing 
multiple independent datasets. Within the Data Portal this supports data discovery, feasibility modelling, access 
management and analysis. The use of a common data model reduces data preparation times and reduces 
uncertainty due to unnecessary variation in data pre-processing.  
For the research community as a whole, a repository facilitates knowledge management including the linking of 
code-to-dataset through the use of persistent identifiers (DOIs), the development and discoverability of APIs for 
rapid replication, and the improvement of the end-to-end user experience through adaptive learning.  
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Repositories have an important role in the democratisation of science. The Data Portal allows remote and secure 
data analysis, enabling the best ideas to be tested in high quality data from any location with suitable connectivity. 
This is fundamentally empowering to researchers without access to high-end computing, particularly in 
developing countries. 
Data Portal Challenges: New infrastructure requires new working practice, which brings challenges to platform 
operators, data controllers and data users.  
Operational challenges for platform operators focus on improving the user experience and increasing the scientific 
opportunity. Data platforms are complex infrastructures that integrate the highest levels of security and 
governance requirements for accessing large, complex, and non-standard datasets. They are also integrated within 
larger computing facilities which require specific resource allocation for computer intensive operations.  
In this context, improving the user experience is an incremental process. For example, improving data discovery 
and visualisation tools to improve the precision of data access requests, streamlining decision making to reducing 
approval times, and developing links to similar resources globally. All involve engagement with different 
stakeholders, each of which have different expectations and requirements.  
For some data controllers the repository ‘trusted third-party’ approach to data management involves uncertainty. 
Whilst the practice of managing access through repeated data transfer may be labour intensive, it is familiar. 
Uncertainty surrounds the legal status of EHR data accessed via the platform, quality of the proposed science, the 
relevance (and existence) of the requested data, and potential conflicts of scientific interest. The legal status of 
accessing EHR data linked to research data using third party platforms is a grey area in the UK. Although there is 
no change in data controller, and no forward sharing to a third-party data controller, current UK data sharing 
licenses have not anticipated the Data Portal solution. Discussions are underway in the UK data community to 
resolve this issue. Wider access also brings reduced control, and data controllers can be concerned over the 
reputation of their datasets if used for egregious science. In response DPUK strongly advises a collaboration with 
cohort research groups as this is the quickest way to understand a dataset and receive expert advice on how to 
approach its analysis. To facilitate good science it is not unreasonable for cohort research teams to insist on a 
collaborative approach. That 61% of declined access requests (see Data Resource Use) were due to the data 
requested either not existing or not being relevant for the analysis is to an extent a matter of due diligence on the 
part of the applicant, but it can also be a matter of judgement. The impact of conflict of interest depends largely 
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on the perspective of the DAC. In an age of increasingly large and complex analyses, many cohorts are 
underpowered for emerging research questions. Cohort research team interests can be well-served though 
transparent collaborative relationships. To reassure data controllers, their approval is required for all data access, 
all use is auditable, data cannot be downloaded, and data are erased upon request. 
For researchers, accessing data via a repository may be less convenient than through their host institution. 
However, the additional security measures are not onerous and are balanced by improved data access. A secure 
repository requires an account and user authentication. Whilst these procedures may be simple (two-factor 
authentication takes ≈10 seconds), they require a level of familiarity before becoming second nature. For access 
approval, epidemiologic, imaging, and genetic communities each have different conventions over what constitutes 
an appropriate data request. By streamlining and standardising the application process DPUK encourages 
coalescence around the development of common standards that are widely accepted. The informatics 
infrastructure required by these groups also varies in terms of operating systems, compute power, and software. 
Our response is to provide flexibility. Standard environments are available that suit the requirements of most 
users, but bespoke environments are built on request including access to high performance computing.  
In the pursuit of scientific rigour, increased data access is only part of the equation. Also required is a 
commensurate development in analytic competence. That 40 project proposals failed a not very demanding triage 
process, suggests that some analysts are unaware of the value and complexity of the data resources that are 
available.  Although DPUK can increase the opportunity for training via the Data Portal, there is a wider 
responsibility to up-skill analysts to take advantage of this. 
Looking ahead: The mission of the Data Portal is to increase the realised scientific value of cohort data. Future 
developments include developing linkage to electronic health records. In partnership with Health Data Research 
UK, DPUK is developing a centralised system enabling DPUK cohorts to link research data to routinely collected 
data. In partnership with Gates Ventures, DPUK along with other platforms is developing global connectivity. 
DPUK is also working with academic and industry partners to provide digital phenotyping using devices such as 
smart phones, for collaborating cohorts. A third development is the use of cohort data to risk-stratify for trials 
recruitment. For dementia, there is a growing need for risk stratification by phenotype according to genotype in 
order to recruit to highly targeted experimental medicine studies. Cohorts, by virtue of lead-in data are well 
positioned to support these studies. DPUK collaborates with the Airwave and Health-Wise Wales cohorts to 
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provide genotyping and cognitive testing for experimental medicine recruitment. DPUK welcomes extending this 
collaboration to other cohorts. 
 
Conclusions: The DPUK Data Portal was established by MRC to support the development of new treatments for 
dementia by using cohort data to inform experimental medicine. It is recognition of the unique value of cohort 
data and a contribution to the wider debate on how best to support cohort studies and facilitate their contribution 
to the wider research environment. By streamlining procedures for cohort research teams, increasing data 
accessibility for researchers, reducing costs, and adding value, the Data Portal is an investment in the future of 
cohort studies.   
Applications for access can be made through the Data Portal https://portal.dementiasplatform.uk/ 
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te or in 
proces
s 
1 Airwave (29) 53,280 Portal Portal  
2 AMPLE (41) 80 Portal Portal  
3 BRACE (42) 2,389 Portal Portal  
4 CamPaIGN (43) 142 Portal Portal  
5 CaPS (24) 2,512 Portal Portal  
6 CFAS I (44) 18,005 Portal Portal  
7 CFAS II (21) 7,524 Portal Portal  
8 DELPHIC (45) 2,000 Portal  Portal   
9 DFP pilot (35) 21 Portal Portal  
10 ELSA (20) 11,391 Portal Portal  
11 EPINEF (46) 2,008 Portal Portal  
12 EXTEND (47) 10,000 Portal Portal  
13 Generation Scotland (48) 23,960 Portal Portal  
14 GERAD EOAD (49) 4,397 Portal Portal  
15 GERAD LOAD (49) 10,454 Portal Portal  
16 ICICLE-PD (50) 318 Portal Portal  
17 Memento (51) 2,323 Portal Portal  
18 NIMROD (52) 276 Portal Cohort  
29 OPDC Discovery (18) 1,589 Portal Portal  
20 PICNICS (53) 282 Portal Portal  
21 SAIL-DeC (33) 1,246,557 Portal Portal  
22 SMC Amyloid (54) 120 Portal Portal  
23 TRACK-HD (19) 366 Portal  Portal  
24 Whitehall II  (25)$ 10,308 Portal + Cohort Cohort  






25 ALSPAC Children (27)$¥ 15,630 Portal + Cohort Cohort  
26 ALSPAC Parents (55)$¥ 22,761 Portal + Cohort Cohort  
27 BDR (23) 2,963 Portal + Cohort Cohort  
28 Cam-CAN (56) 2,683 Portal + Cohort Cohort  
29 CHARIOT (57) 24,509 Portal + Cohort Cohort  
30 DIAN (16) 437 Portal Cohort  
31 EPIC Norfolk (28) 25,639 Portal + Cohort Cohort  
32 HealthWise Wales (32) 6,100 Portal + Cohort Cohort  
33 LBC1936 (58)¥ 1,091 Portal + Cohort Cohort  
34 Million Women (30) 1,319,475 Portal + Cohort Cohort  
35 NICOLA (59) 8,504 Portal Cohort  
36 NSHD (26) 5,362 Portal + Cohort Cohort  
37 PREVENT (60) 700 Portal Cohort  
38 PRIME (61) 2,745 Portal Cohort  
39 PROTECT (62) 14,000 Portal + Cohort Cohort  
40 SABRE (63) 4,858 Portal + Cohort Cohort  
41 UK Biobank (31)* $ 502,655 Cohort Cohort  
42 UK GENFI (17) 515 Portal Cohort  
  Total 3,370,929    
 
Notes: 
1 Data access process: Portal:    DPUK procedure sufficient 
Cohort Cohort specific procedure required 
Portal + Cohort:  DPUK procedure may be used for the initial 
application, followed by cohort-specific 
procedure 
2           Variable selection Portal:   DPUK procedure sufficient 
  Cohort:   Cohort specific procedure required 
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$         Data access fee payable 
¥         Data uploaded directly to the applicants servers 





Figure: Data Portal architecture 
